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Background: A published report of surgical site infection (SSI) incidence and risk factors following laparotomy in a South African 
(SA) setting is lacking. This information would have important implications for SSI clinical prediction rules in SA patients 
undergoing this common surgical procedure. This study sought to determine the incidence and associated risk factors for SSI 
following laparotomy in a SA setting. 
Methods: This was a retrospective chart review study of 439 patients who underwent laparotomy at a SA quaternary hospital 
over a 5-year period. Demographic information, comorbidities, medication use, and surgery-related variables were collected for 
each patient. The Centers for Disease Control definition of SSI was used in this study. The incidence of SSI was determined using 
conventional epidemiological methods. Logistic regression was used to identify risk factors for SSI.  
Results: The incidence of SSI was 16.6% (CI: 13.4-20.4%). Risk factors for SSI included infectious indication for surgery (Odds 
Ratio, OR: 3.32, CI: 1.16-9.47; p=0.003), preoperative non-steroidal anti-inflammatory use (OR: 2.82, CI: 1.33-5.95; p=0.007), 
preoperative hypoalbuminemia (OR: 2.47, CI: 1.12-5.42; p=0.025), Bogota bag use (OR: 2.23, CI: 1.05-4.74; p=0.036), and 
perioperative blood transfusion (OR: 2.51, CI: 1.33-4.75; p=0.004).     
Conclusion: The incidence of SSI in SA patients undergoing laparotomy is higher than that reported for mixed surgical 
populations. Several risk factors for SSI were identified. The prognostic relevance of these risk factors, and the reduction in SSI 
risk when these factors are addressed requires further investigation.  
 






Over 234 million people undergo surgery around the world 
each year [1]. A proportion of these patients will suffer 
postoperative complications, with surgical site infection 
(SSI) being amongst the most commonly encountered [2]. 
Findings from the International Surgical Outcomes Study 
(ISOS) suggest that the global incidence of SSI is between 
0.8% for organ space SSI and 2.9% for superficial SSI [2]. 
ISOS also reported that mortality in patients with SSI was 
between 1.3% for patients with superficial SSI and 7.0% for 
patients with organ space SSI [2]. The African Surgical 
Outcomes Study (ASOS) reported a higher incidence of SSI 
in African settings, ranging from 1.1% for organ space SSI to 
7.2% for superficial SSI [3]. Mortality in patients with SSI 
was also higher in ASOS when compared with ISOS, and 
ranged between 5.2% for superficial SSI to 22.4% for organ 
space SSI [3]. Information for healthcare expenditure 
related to SSIs in African settings is not readily available.  
However, it is likely that there is an association between 
SSIs and increased healthcare expenditure in African 
settings, as is the case in other countries around the world 
[4, 5].  
The morbidity, mortality, and potentially increased 
healthcare expenditure associated with SSIs in African 
settings highlights the importance of identifying individual 
patients who might be at risk for this complication in these 
settings. These patients can then be targeted for additional 
preventative interventions for SSI which are over and above 
those interventions that are instituted as standard of care, 
in order to mitigate some of this risk. Targeting individual 
high-risk patients for additional SSI prevention 
interventions rather than all surgical patients would also 
ensure that this process would not be too resource 
intensive. This point is relevant in African settings, where 
public healthcare systems are often under-resourced. 
Clinical prediction rules are one possible method which can 
be used to identify high-risk patients for SSI [6, 7]. This 
method involves the identification of high-risk patients 
based on the number of risk factors for a specific 
complication. Every risk factor carries a point score, and a 
total point score is computed for each patient [8]. A total 
point score threshold is determined which is then used to 
classify patients as high-risk or low-risk for the complication 
[8]. Studies for other postoperative outcomes suggest that 
some clinical prediction rules might not perform equally 
well in African surgical settings and in overseas surgical 
settings where these methods were originally developed 
[9]. This can be attributed to the difference in the general 
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health profiles between surgical populations in these 
different settings, which might then impact the relative 
importance of a risk factor between these different settings 
[9]. Risk factors for SSI following common major surgical 
procedures, such as laparotomy, in a South African (SA) 
setting have not yet been identified. This information would 
have great importance with regard to the development of a 
setting-specific clinical prediction rule for SSI. Therefore, 
the objective of this study was to determine the incidence 
and associated risk factors for SSI following laparotomy at a 
SA quaternary hospital. 
 
 
Patients and methods 
Study design and setting: 
This retrospective chart review study was conducted at a 
quaternary hospital located in Durban, SA. The 850-bed 
quaternary hospital is a public-sector facility and provides 
various healthcare services to the residents of KwaZulu-
Natal province, which is on the east coast of SA. Admission 
to the hospital is strictly by referral from lower level 
healthcare facilities. The population served by the hospital 
is predominantly of black African ethnicity. 
Study sample: 
The study sample consisted of 439 adult patients 
undergoing laparotomy. These patients were 
retrospectively identified from the hospital theater lists. All 
439 patients had their surgical procedures performed 
between 1 January 2006 and 31 December 2010. 
Data collection: 
Demographic information, comorbidities, medication use, 
and surgery-related variables were collected for each 
patient. Demographic information was collected from the 
patients’ admission note. A comorbidity was considered 
present if there was a physicians’ diagnosis attesting to this 
in the patients’ admission notes or progress notes. The 
indication for surgery was classified as bleed, cancer, 
infection, trauma, or other. Indication for surgery was 
established from the operative notes.  Medication use was 
ascertained from the patients’ admission notes or from the 
list of medications administered to the patient while he or 
she was admitted to hospital. Information for surgery-
related variables were obtained from the operative notes 
and anesthetic record of each patient. The study outcome 
was SSI following laparotomy. The Centers for Disease 
Control (CDC) definition of SSI requires the evidence of 
clinical signs and symptoms of infection and is not solely 
based on microbiological evidence of infection [10]. Clinical 
signs and symptoms of infection can include the following: 
swelling and redness, pain at the site of surgical incision, 
presence of pus, fever, surgical wound dehiscence, or 
histopathological or radiological evidence of infection. The 
CDC further categorizes SSI according to the extent of the 
infection (Superficial incisional, deep incisional, and organ 
space infection) [10]. The CDC definition of SSI was used in 
this study, however there was no additional categorization 
according to the extent of the infection as all SSIs in this 
study were deemed to be of importance, irrespective of the 
extent of the infection. The SSI outcome was measured up 
to 30 days postoperatively.   
Statistical analysis: 
Descriptive statistical methods were used to determine the 
distribution of various characteristics in the study sample. 
Results for the descriptive statistical analysis are presented 
as frequencies and percentages. The incidence of SSI in the 
study sample was calculated using conventional 
epidemiological equations.  Results for this aspect of the 
statistical analysis are presented as a percentage along with 
a 95% confidence interval (CI). Potential statistical 
associations between the various characteristics and SSI 
were initially tested using bivariate statistical analysis (χ2 
test or Fishers Exact test). Results for the bivariate 
statistical analysis are presented as frequencies and 
percentages, along with a corresponding p-value. 
Characteristics with p<0.100 from the bivariate statistical 
analysis were then selected for inclusion as independent 
variables in a logistic regression analysis, with SSI being the 
dependent variable. This “purposeful” selection of 
characteristics for inclusion in the logistic regression 
analysis was performed to ensure that the subsequent 
regression model was parsimonious [11]. The fit of the 
regression model was evaluated using the Hosmer-
Lemeshow test, with p>0.050 indicative of appropriate 
model fit. Results for the regression analysis are presented 
as odds ratios (OR) with CI, and a corresponding p-value. 
Characteristics with an OR >1.00 and p<0.050 were 
classified as risk factors for SSI. All statistical analyses were 
performed using the Statistical Package for the Social 
Sciences (SPSS) version 25.0 (IBM Corp, USA). 
Ethical approval: 
This study was approved by the Biomedical Research Ethics 
Committee of the University of KwaZulu-Natal, and the 




The characteristics of the study sample, as well as the 
results of the bivariate statistical analysis are presented in 
Table 1. Out of the 439 patients undergoing laparotomy in 
the study sample, 73 patients were identified as having SSI 
following their procedure. This equated to an estimated SSI 
incidence of 16.6% (CI: 13.4-20.4%) in the study sample. 
Variables with p<0.050 which were subsequently included 
in the logistic regression analysis included: indication for 
surgery, American Society of Anesthesiologists Score, 
preoperative non-steroidal anti-inflammatory use, 
metastatic cancer, preoperative renal impairment, 
preoperative anemia, preoperative hyponatremia, 
preoperative hypoalbuminemia, emergency procedure, 
contaminated procedure, Bogota bag use, antibiotic 
prophylaxis, and preoperative blood transfusion.  
The results of the logistic regression analysis are shown in 
Table 2. The Hosmer-Lemeshow test indicated appropriate 
model fit (p=0.381). Statistically significant results were 
noted for infectious indication for surgery (OR: 3.32, CI: 
1.16-9.47; p=0.025), preoperative non-steroidal anti-
inflammatory use (OR: 2.82, CI: 1.33-5.95; p=0.007), 
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preoperative hypoalbuminemia (OR: 2.47, CI: 1.12-5.42; 
p=0.025), Bogota bag use (OR: 2.23, CI: 1.05-4.74; p=0.036), 
and perioperative blood transfusion (OR: 2.51, CI: 1.33-
4.75; p=0.004).  
 
Table 1. Characteristics of the study sample and results of bivariate statistical analysis 
Characteristic Category All (N=439),  
n (% N) 
SSI (N=73),  
n (% N) 
No SSI (N=366),  
n (% N) 
p  
Age>60 >60 years 82 (18.7) 11 (15.1) 71 (19.4) 0.386  
≤60 years 357 (81.3) 62 (84.9) 295 (80.6) 
 
Gender Male 145 (33.0) 26 (35.6) 119 (32.5) 0.607  
Female 294 (67.0) 47 (64.4) 247 (67.5) 
 
Obesity Yes 152 (34.6) 31 (42.5) 121 (33.1) 0.302  
No 105 (23.9) 15 (20.5) 90 (24.6) 
 
 
Missing 182 (41.5) 27 (37.0) 155 (42.3) 
 
Indication for surgery Bleed 12 (2.7) 2 (2.8) 10 (2.7) <0.001 
 Cancer 183 (41.7) 19 (26.0) 164 (44.8)  
 Infection 36 (8.2) 19 (26.0) 17 (4.6)  
 Other 151 (34.4) 19 (26.0) 132 (36.1)   
Trauma 57 (13.0) 14 (19.2) 43 (11.8) 
 
American Society of Anesthesiologists Score >2 207 (47.2) 44 (60.3) 163 (44.5) 0.014  
≤2 232 (52.8) 29 (39.7) 203 (55.5) 
 
Preoperative non-steroidal anti-inflammatory Yes 62 (14.1) 17 (23.3) 45 (12.3) 0.014  
No 377 (85.9) 56 (76.7) 321 (87.7) 
 
Preoperative statin Yes 25 (5.7) 6 (8.2) 19 (5.2) 0.280  
No 414 (94.3) 67 (91.8) 347 (94.8) 
 
Hypertension  Yes 140 (31.9) 26 (35.6) 114 (31.1) 0.454  
No 299 (68.1) 47 (64.4) 252 (68.9) 
 
Diabetes  Yes 57 (13.0) 13 (17.8) 44 (12.0) 0.179  
No 382 (87.0) 60 (82.2) 322 (88.0) 
 
Cardiovascular disease Yes 50 (11.4) 5 (6.8) 45 (12.3) 0.181  
No 389 (88.6) 68 (93.2) 321 (87.7) 
 
HIV Yes 30 (6.8) 2 (2.7) 28 (7.7) 0.200  
No 409 (93.2) 71 (97.3) 338 (92.3) 
 
Metastatic cancer Yes 86 (19.6) 9 (12.3) 77 (21.0) 0.087  
No 353 (80.4) 64  (87.7) 289 (79.0) 
 
Obstructive airway disease Yes 25 (5.7) 6 (8.2) 19 (5.2) 0.280  
No 414 (94.3) 67 (91.8) 347 (94.8) 
 
Gastric ulcers Yes 17 (3.9) 4 (5.5) 13 (3.6) 0.502  
No 422 (96.1) 69 (94.5) 353 (96.4) 
 
Current smoker Yes 44 (10.0) 7 (9.6) 37 (10.1) 0.892  
No 395 (90.0) 66 (90.4) 329 (89.9) 
 
Preoperative leukopenia Yes 35 (8.0) 6 (8.2) 29 (7.9) 0.932  
No 404 (92.0) 67 (91.8) 337 (92.1) 
 
Preoperative thrombocytosis Yes 47 (10.7) 7 (9.6) 40 (10.9) 0.735  
No 392 (89.3) 66 (90.4) 326 (89.1) 
 
Preoperative renal impairment Yes 67 (15.3) 18 (24.7) 49 (13.4) 0.014  
No 372 (84.7) 55 (75.3) 317 (86.6) 
 
Preoperative anemia Yes 314 (71.5) 62 (84.9) 252 (68.9) 0.005  
No 125 (28.5) 11 (15.1) 114 (31.1) 
 
Preoperative hyponatremia Yes 54 (12.3) 14 (19.2) 40 (10.9) 0.050  
No 385 (87.7) 59 (80.8) 326 (89.1) 
 
Preoperative hypoalbuminemia Yes 159 (36.2) 48 (65.8) 111 (30.3) <0.001  
No 280 (63.8) 25 (34.2) 255 (69.7) 
 
Emergency procedure Yes 150 (34.2) 36 (49.3) 114 (31.1) 0.003  
No 289 (65.8) 37 (50.7) 252 (68.9) 
 
Contaminated procedure Yes 88 (20.0) 31 (42.5) 57 (15.6) <0.001  
No 351 (80.0) 42 (57.5) 309 (84.4) 
 
Surgery duration >2 hours Yes 153 (34.9) 20 (27.4) 133 (36.3) 0.143  
No 286 (65.1) 53 (72.6) 233 (63.7) 
 
Bogota bag Yes 70 (15.9) 47 (64.4) 322 (88.0) <0.001  
No 369 (84.1) 26 (35.6) 44 (12.0) 
 
Antibiotic prophylaxis Yes 366 (83.4) 55 (75.3) 311 (85.0) 0.044  
No 73(16.6) 18 (24.7) 55 (15.0) 
 
Perioperative blood transfusion Yes 157 (35.8) 46 (63.0) 111 (30.3) <0.001  
No 282 (64.2) 27 (37.0) 255 (69.7) 
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Patient-controlled analgesia postoperatively Yes 33 (7.5) 3 (4.1) 30 (8.2) 0.227  
No 406 (92.5) 70 (95.9) 336 (91.8) 
 
 
Table 2. Results of the logistic regression analysis 
Characteristic Category OR (CI) p 
 
Indication for surgery Bleed 0.44 (0.08-2.57) 0.361 
 Cancer 1.03 (0.34-3.10) 0.961 
 Infection 3.32 (1.16-9.47) 0.025 
 Other 0.78 (0.31-1.94) 0.588 
 Trauma/injury 1.00 (Reference group) - 
American Society of Anesthesiologists Score >2 1.36 (0.75-2.48) 0.313 
 ≤2 1.00 (Reference group) - 
Preoperative non-steroidal anti-inflammatory Yes 2.82 (1.33-5.95) 0.007 
 No 1.00 (Reference group) - 
Metastatic cancer Yes 0.46 (0.20-1.10) 0.080 
 No 1.00 (Reference group) - 
Preoperative renal impairment Yes 0.99 (0.45-2.17) 0.970 
 No 1.00 (Reference group) - 
Preoperative anemia Yes 1.25 (0.57-2.75) 0.582 
 No 1.00 (Reference group) - 
Preoperative hyponatremia Yes 1.35 (0.61-3.00) 0.458 
 No 1.00 (Reference group) - 
Preoperative hypoalbuminemia Yes 2.47 (1.12-5.42) 0.025 
 No 1.00 (Reference group) - 
Emergency procedure Yes 0.59 (0.26-1.31) 0.194 
 No 1.00 (Reference group) - 
Contaminated procedure Yes 1.22 (0.58-2.55) 0.599 
 No 1.00 (Reference group) - 
Bogota bag Yes 2.23 (1.05-4.74) 0.036 
 No 1.00 (Reference group) - 
Antibiotic prophylaxis Yes 0.66 (0.32-1.34) 0.247 
 No 1.00 (Reference group) - 
Perioperative blood transfusion Yes 2.51 (1.33-4.75) 0.004 
 No 1.00 (Reference group) - 
 
Discussion 
The incidence of SSI in this study was far higher than that 
reported for ISOS and ASOS [2, 3]. It is possible that this 
finding is due to one crucial difference between the current 
study and ISOS/ASOS, which is that the current study was 
performed solely in a high-risk major surgery group while 
ISOS and ASOS were performed in surgical populations 
which were a mix of major and minor surgical procedures 
[2, 3]. Open intra-abdominal surgery itself is associated with 
an increased risk of developing SSI [12]. It is likely that the 
SSI incidence in ISOS and ASOS was “diluted” by the 
inclusion of lower risk surgical procedures in these two 
studies. 
Several risk factors for SSI were identified in this study, 
which confirms the established view of SSI as being 
multifactorial [13]. These risk factors were infectious 
indication for surgery, preoperative non-steroidal anti-
inflammatory use, preoperative hypoalbuminemia, Bogota 
bag use, and perioperative blood transfusion. These 
characteristics were associated with an approximately two- 
to three-fold increase in risk for SSI. The immune response 
provides protection against infection. Therefore, when 
there is a perturbation in the immune response an 
individual might be more susceptible to infection. The 
finding for infectious indication for surgery being associated 
with a higher risk of SSI is probably reflective of underlying 
immune dysfunction in patients with pre-existing infection. 
Nonsteroidal anti-inflammatory medications are often 
prescribed for pain control during the perioperative period 
[14]. These are also often given when patient is discharged 
from hospital for pain control, and can be administered 
orally or as a suppository. As the name implies, these 
medications control pain by reducing inflammation [15]. 
This might contribute to an impaired immune response in 
surgical patients, resulting in a predisposition to SSI. The 
link between hypoalbuminemia and a higher risk of SSI is 
well established [16, 17]. Hypoalbuminemia is often 
considered a sign of malnutrition [18].  Besides impairment 
of the immune response, malnutrition might also cause 
impaired wound healing [19].  The intact integument acts as 
a physical barrier against infection and surgical incisions, 
which represent disruptions in the integumentary system 
[20], would remain open for far longer in malnourished 
individuals. During this time period the disrupted 
integument at the site of the surgical incision might be 
susceptible to bacterial colonization [20]. Similarly, the use 
of a Bogota bag would also leave the disrupted integument 
susceptible to bacterial colonization [21].  Some blood loss 
is inevitable during open intra-abdominal surgery [22, 23]. 
Perioperative transfusion might be proposed to address 
perioperative blood loss. However, transfusion itself has 
been found to be associated with an increased risk of 
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several postoperative complications, including SSI [24]. In 
agreement with the pathophysiology of other risk factors 
identified in this study, it has been postulated that 
perioperative transfusion might impair the immune 
response. This appears to be supported by the findings of a 
recent study involving patients undergoing gastrointestinal 
surgery, wherein there was an immunosuppressive gene 
expression profile exhibited by patients who had received a 
perioperative blood transfusion [25]. The study had 
specifically found that that this gene expression profile 
could have a profoundly negative impact on cells of innate 
immune response [25], which would therefore make 
patients who received blood transfusions at higher risk for 
postoperative infectious complications. 
We recommended that additional cohort studies be 
conducted in order to investigate the prognostic 
performance of these risk factors as components of a SSI 
clinical prediction rule. This would assist with the 
preoperative identification of patients who are at high-risk 
for SSI following their procedures. It might also be worth 
considering the potential benefits of trying to address some 
of the SSI risk factors identified in this study. This could 
mitigate a portion of the risk for SSI in high-risk patients. 
For instance, pain in surgical patients could be managed 
using other analgesics. Malnourished patients should be 
offered adequate nutritional support [26]. Optimizing 
surgical technique and the use of anti-fibrinolytic agents are 
strategies which can be used to prevent excess 
perioperative blood loss [27]. This could reduce the need 
for a perioperative blood transfusion. Where there is no 
option for patients other than blood transfusion, then these 
patients should have their surgical incisions reviewed more 
often during the postoperative period for SSI. One cannot 
mitigate the risk of SSI associated with the indication for 
surgery. Furthermore, one cannot completely mitigate for 
the risk of SSI associated with the use of a Bogota bag. 
These risk factors can be used to identify high-risk patients 
for more stringent postoperative monitoring. 
There were limitations to this research. This study was 
conducted at a single, quaternary level hospital. The patient 
profile at this hospital is that of very complex cases which 
cannot be managed at lower level healthcare facilities. 
Therefore, the findings of this research might not 
necessarily be generalizable to other hospitals or other 
surgical populations. Information regarding the use of over-
the-counter and herbal medications, which might have an 
immune boosting effect in surgical patients, was not 
collected as part of this study as it was difficult to 
retrospectively establish the use of these medications from 
the patients’ medical chart. There were also some variables 
which were not consistently recorded on the patients’ 
notes, for example the composition of suture material used 
to close the surgical incision. These variables could not be 
reliably investigated in this study and were excluded from 
the statistical analysis. The study outcome was only 
measured until 30 days postoperatively, which is in keeping 
with the CDC definition for SSI. However, there might 
possibly have been some patients with delayed SSI, in that 
they presented with SSI at a time point which fell outside 
the 30 day postoperative period. These patients would have 
been considered as SSI-negative in the statistical analysis. 
Prospective research studies are required to address all the 
aforementioned limitations. 
In conclusion, the incidence of SSI observed in the 
study sample of SA patients undergoing laparotomy was 
much higher than that reported in larger studies involving 
mixed surgical populations. This study also identified 
several risk factors for SSI following laparotomy in a SA 
setting. The prognostic relevance of these risk factors, and 
the reduction in SSI risk when these factors are addressed 
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